Cancer Channel
Related Channels

What Is Cabazitaxel Used For?

Cabazitaxel is licensed for the treatment of prostate cancer in men age 18 and older. Using this drug for treating other types of cancer or in combination with other types of chemotherapy would be considered an off-label (unapproved) use of cabazitaxel. This prescription medication works by interfering with certain cell structures, which prevents the cancer from growing and multiplying.

An Overview of Uses for Cabazitaxel

Cabazitaxel (Jevtana®) is a prescription medication approved for the treatment of prostate cancer. It is reserved for "refractory" cases of prostate cancer that have not responded adequately to hormone therapy in people who have already tried docetaxel (Taxotere®).
A prostate cancer diagnosis means that cancer cells have formed in the tissues of the prostate. This disease tends to grow slowly compared with most other cancers. Cell changes may begin 10, 20, or 30 years before a tumor gets big enough to cause symptoms. Eventually, cancer cells may spread (metastasize) throughout the body. By the time symptoms appear, the cancer may be more advanced.
Most cases of prostate cancer never pose a problem. There are either no signs or symptoms, or the disease never becomes a serious threat to a man's health. A much smaller percentage of men are actually treated for prostate cancer. Most men with the condition, however, do not die from this disease. The prognosis varies, depending on the stage (see Prostate Cancer Prognosis and Stages of Prostate Cancer).
In addition, you may have a combination of treatment methods.
5 Questions to Ask Your Doctor About ED

Cabazitaxel Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.